Holy Basil (Tulsi) for Blood Sugar Regulation

Research suggests that Holy Basil (Tulsi, Ocimum sanctum/tenuiflorum) may support blood sugar regulation through multiple mechanisms, including stimulating insulin secretion, improving insulin sensitivity, and inhibiting carbohydrate-digesting enzymes such as alpha-glucosidase and alpha-amylase. Studies indicate that the evidence base includes systematic reviews of Ayurvedic herbs, multiple narrative reviews synthesizing in vitro and animal data, at least one human clinical study showing improved plasma insulin and reduced insulin resistance in overweight and obese subjects, and a computational study identifying tulsi compounds as potential DPP4 inhibitors — with the overall direction of findings consistently supportive. Key bioactive constituents, particularly eugenol, are frequently cited across reviews as central to these antidiabetic effects. However, important limitations apply: the majority of evidence comes from animal and laboratory studies or narrative reviews rather than large, well-controlled human trials, and researchers across multiple publications have called for more rigorous clinical studies to clarify optimal use, mechanisms, and the populations most likely to benefit.